Wishing All Our Readers, Sponsors, Advertisers, Listers A Happy And Prosperous Chinese New Year 2020

BREAKING NEWS
Diabetes
There are roughly about 4 million Thais and about 380,000 expats in Thailand afflicted with this disease. Keep updated with ways to control and manage diabetes while also monitor what’s developing in the research sector of this disease.
Presented by
Source: Thailand Medical News  Jan 10, 2020
A breakthrough discovery that could improve the clinical delivery of insulin for people living with diabetes, medical scientists from Australia have developed a non-fibrillating form of human insulin. Utilizing a novel glycosylation technique, an international research team led by Associate Professor Dr Akhter Hossain from the Florey Institute of Neuroscience and Mental Health, has successfully...
Source: Thailand Medical News  Dec 24, 2019
Medical researchers at Karolinska Institutet in Sweden have deciphered the diabetogenic role of a certain type of calcium channel in insulin-secreting beta cells. The researchers believe that blockade of these channels could be a potential new treatment strategy for diabetes. The recent study is published in the scientific journal PNAS. The CaV3.1 channels have a marginal role in healthy ...
Source: Thailand Medical News  Nov 22, 2019
A new broad European study involving multiple medical institutes finds that patients with diabetes do not benefit from implantable cardioverter defibrillator (ICD) pacemakers. Typically, current treatment recommendations support ICD pacemaker treatment for all patients with severe malfunction of the left ventricle. The purpose of the defibrillator is to protect the patient from life-threatening...
Source: Thailand Medical News  Nov 05, 2019
Pharma giant Sanofi has announced that its Toujeo (insulin glargine 300units/mL) is effective at reducing average blood sugar (HbA1c) in children and adolescents with type 1 diabetes, compared to insulin glargine 100units/mL (Gla-100). In the Phase III EDITION-JUNIOR study of 463 children and adolescents over the age of six, Toujeo met its primary endpoint of non-inferior reduction of HbA1c compa...
Source: Thailand Medical News  Sep 24, 2019
Thailand Diabetes Researchers from Charles University in Prague have found that real-time continuous glucose monitoring (rtCGM) is effective among those with type 1 Diabetes irrespective of what modalities are used to deliver insulin to the body.   The three year trial called COMISAIR (Comparison of Different Treatment Modalities for Type 1 Diabetes Including Sensor-Augmented Insulin Regim...
Source: Thailand Medical News  Jul 21, 2019
Endowed Professor  of Cardiovascular Medicine from the University Of California-Davis, Dr Nipavan Chiamvimonvat who has a long litany of professional and international awards and more than 135 medical research papers published, has once again with her team made another major discovery as to the actual mechanism as to how diabetes causes vascular disease. Prof Dr Nipavan Chiamvomonvat Toget...
Source: Thailand Medical News  Jun 10, 2019
Findings from the Rewind (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) Trial by McMaster University and Hamilton Health Sciences , has indicated that the drug dulaglutide (brandname: Trulicity) reduced cardiovascular events and kidney problems in middle-aged and older people with Type 2 diabetes. The trial which was one of the largest of its kind involved more than 9,90...
Source: Thailand Medical News  Jun 06, 2019
A new discovery by a research team from Heidelberg University in Germany reveals that lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy (DPN).  Diabetic neuropathy is a type of nerve damage that occurs when an individual has diabetes. High blood sugar (glucose) can injure nerves throughout the body. Diabetic neuropathy most often ...
Source: Thailand Medical News  Jun 02, 2019
Diabetic retinopathy is the leading cause of blindness in adults across the world, but the most  challenging aspect of the disease is that it often goes undetected until too much damage has been done and the person affected is already losing their vision. Most diabetics have few treatment options as the severity of the condition and vision loss worsens.   Regeneron Pharmaceuticals D...
Source: Thailand Medical News  May 18, 2019
Diabetes  affects about 442 million people worldwide (2019) and the figures keep rising with Thailand alone having more than 4.7 million people with diabetes.   Diabetes is the result when a person’s body is not able to produce enough insulin naturally (type 1 diabetes) or when the insulin produced is not efficiently used in the body (type 2 diabetes). Insulin is  produced i...
Source: Harvard Medical School, Boston  May 10, 2019
Statin use may lower the risk for primary open-angle glaucoma (POAG), according to a study published online May 2 in JAMA Ophthalmology.   High cholesterol is associated with an increased risk of developing glaucoma, but a new study suggests taking statins to lower cholesterol helps to reduce this risk.   Glaucoma is a group of eye conditions that can damage the optic nerve, typic...
Source: US FDA  May 08, 2019
If you have type 2 diabetes and are taking a newer class of medications to treat your disease—but one day you notice pain, redness and a foul odor in your genital area.If this happens, new research suggests you need to see your doctor immediately, because you may be suffering from Fournier gangrene. Also known as a "flesh-eating" disease, this infection attacks your genital or anal...
Source: National Institutes of Health,US  May 02, 2019
Taking a folic acid supplement daily before pregnancy may reduce the risk of gestational, or pregnancy-related, diabetes, according to a study by researchers at the National Institutes of Health and other institutions.    Folic acid is the synthetic form of folate, or vitamin B9, which is found in leafy green vegetables, nuts, peas, beans and other foods. The U.S. Preventive Services T...
Source: University of Texas Health Science Center at San Antonio  May 01, 2019
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced at the Pediatric Academic Societies 2019 meeting in Baltimore, Md.  Study coauthor Jane Lynch, M.D., FAAP, professor of pediatrics at UT Health San Antonio, said the drug, liraglutide, in combination with an existing medication, metformin, showed robust effect in treating chi...